Participating hospitals reduced mortality among sepsis patents during the study period by 44 percent, 1-year poststudy mortality decreased by 54.5 percent, and the initiative has generated a positive return on investment.
Since program implementation, the rates of ventilator-associated pneumonia, central line infections and pressure ulcers have decreased, intensive care unit (ICU) readmissions have declined, ICU length of stay remains low, and testing and pain management education have increased.